Literature DB >> 15467919

Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study.

Xiaoyang Zhou1, Jianfeng Huang, Jianhong Chen, Shaoyong Su, Runsheng Chen, Dongfeng Gu.   

Abstract

Matrix metalloproteinase (MMP) 3 plays an important role in the pathogenesis of myocardial infarction (MI). Up to now, there has been conflicting data regarding the possible contribution of the MMP3 -1612 5A/6A promoter polymorphism to MI. In this study, we have investigated the possible association of three polymorphisms (-1612 5A/6A, -376C/G, Glu45Lys) in the MMP3 gene with MI in a Chinese Han population. The polymorphisms were analyzed in 509 patients with MI, and in 518 healthy controls. The frequency of the 5A allele was 14% in the healthy controls, which is less than in Western populations (40%-52%). Logistic regression analyses of individual polymorphisms indicated that individuals carrying the -1612 5A allele had an increased risk of MI (odds ratio [OR] 1.75, 95% confidence interval [CI] 1.28 to 2.40), as did those carrying the -376 G allele (OR 1.78, 95% CI 1.33 to 2.38). The three polymorphisms studied were found to be in strong linkage disequilibria. Haplotype analyses showed that the 5A-G-Lys haplotype (-1612 5A, -376G and 45Lys) was independently associated with susceptibility to MI. Taken together, the effect of the MMP3 polymorphisms studied may be attributable to the -1612 5A/6A polymorphism. We conclude that the MMP3 -1612 5A/6A polymorphism is associated with MI in our population, implying that individuals of the 5A allele carriers have an increased risk of suffering MI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467919     DOI: 10.1160/TH04-03-0192

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

1.  Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.

Authors:  Benjamin D Horne; Nicola J Camp; John F Carlquist; Joseph B Muhlestein; Matthew J Kolek; Zachary P Nicholas; Jeffrey L Anderson
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

Review 2.  Genetic determinants of carotid ultrasound traits.

Authors:  Rebecca L Pollex; Robert Hegele
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

Review 3.  Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction.

Authors:  Timmy Lee; Davinder Wadehra
Journal:  Semin Dial       Date:  2011-09-15       Impact factor: 3.455

4.  Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients.

Authors:  Chih-Ching Lin; Wu-Chang Yang; Ming-Yi Chung; Pui-Ching Lee
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 8.237

Review 5.  The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis.

Authors:  Sonia Abilleira; Steve Bevan; Hugh S Markus
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

6.  Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.

Authors:  Robert C Kaplan; Nicholas L Smith; Stanley Zucker; Susan R Heckbert; Kenneth Rice; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2008-03-14       Impact factor: 5.162

7.  Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population.

Authors:  Kavita K Shalia; V K Shah; M R Mashru; S L Soneji; J B Vasvani; S Payannavar; A Walvalkar; R Mokal; S S Mithbawkar; M Bootwalla; P Sadvekar; P K Thakur
Journal:  Indian J Clin Biochem       Date:  2010-05-27

8.  MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study.

Authors:  Kelly A Volcik; Stephen Campbell; Lloyd E Chambless; Josef Coresh; Aaron R Folsom; Thomas H Mosley; Hanyu Ni; Lynne E Wagenknecht; Bruce A Wasserman; Eric Boerwinkle
Journal:  Atherosclerosis       Date:  2009-12-11       Impact factor: 5.162

Review 9.  Matrix metalloproteinases and myocardial infarction.

Authors:  Wannakorn Phatharajaree; Arintaya Phrommintikul; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2007-07       Impact factor: 5.223

10.  Genetic polymorphisms and the risk of myocardial infarction in patients under 45 years of age.

Authors:  Agata Sakowicz; Wojciech Fendler; Malgorzata Lelonek; Bartosz Sakowicz; Tadeusz Pietrucha
Journal:  Biochem Genet       Date:  2012-12-30       Impact factor: 1.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.